Who is sponsoring NCT04389125?

NCT04389125 is sponsored by Chonbuk National University Hospital.

What drugs are being tested in NCT04389125?

Interventions in NCT04389125: Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures, Placebo.

What condition does NCT04389125 study?

NCT04389125 studies Blood Flow.

Is NCT04389125 still recruiting?

NCT04389125 is currently status unknown. Last updated 15 May 2020.

Last reviewed 2020-05-15 · How we verify

NCT04389125

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Safety of Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures on the Improvement of Blood Flow

Status unknown NA Last updated 15 May 2020

What this trial tests

NA trial testing Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures in Blood Flow in 80 participants. Status unknown.

Timeline

30 January 2020

Primary endpoint
30 April 2021

30 May 2021

Quick facts

Lead sponsor	Chonbuk National University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	80
Start date	30 January 2020
Primary completion	30 April 2021
Estimated completion	30 May 2021
Sites	1 location across South Korea

Drugs / interventions tested

Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures
Placebo

Conditions studied

Blood Flow — all drugs for Blood Flow →

Sponsor

Chonbuk National University Hospital

Who can join

Adults 19 to 80, any sex, with Blood Flow. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to investigate the effects of daily supplementation of Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures on the Improvement of Blood Flow.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy - active Phytochemicals and In Vivo Molecular Targets.
Lü J, Jiang C, Drabick JJ, Joshi M, et al · · 2025 · cited 1× · PMID 39779619 · DOI 10.1007/s11095-024-03809-9

Verify or expand the search:

Other recruiting trials for Blood Flow

Currently open trials in the same condition.

NCT06672952 — Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Othe · NA · recruiting
NCT06882733 — The Immediate Effect of Applying Transcutaneous Electrical Nerve Stimulation (TENS) on Sympathetic Ganglion and Gastrocn · NA · recruiting
NCT06520982 — Early Neurovascular Adaptations in Aging Women · EARLY_PHASE1 · recruiting
NCT06238609 — Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome · NA · active not recruiting
NCT06192992 — Regional Blood Flow During Peripheral Heating · NA · recruiting

Other Chonbuk National University Hospital trials

Trials by the same sponsor.

NCT05324800 — the Efficacy and Safety of Curcuma Longa Extract Mixture on Immune Enhancement · NA · unknown
NCT05450939 — Characteristics of Signal Intensity Gradient in Subarachnoid Hemorrhage After Aneurysmal Rupture · unknown
NCT05190237 — the Efficacy and Safety of Fermented Soybean(Doenjang Powder) on Intestinal Microflora and Immune Enhancement. · NA · completed
NCT05495191 — Signal Intensity Gradient in Cerebral Arteries · completed
NCT04940910 — The Efficacy and Safety of Black Rice Bran Extract on Immune Enhancement · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04389125 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chonbuk National University Hospital
Last refreshed: 15 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04389125.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing